Reading view
MITF-SCD1 Lipid Metabolic Axis Prevents Ouabain-Induced Spiral Ganglion Neuron Ferroptosis and Hearing Loss
JarvisGUI: Towards Cross-Device GUI Agents with Dynamic Task Composition
FrogNano: Training a 4B Coding Agent via Online Task Synthesis
The Biggest Risk of Embodied AI is Governance Lag
Integrated single-cell multi-omics characterization reveals lipid-associated macrophage-mediated immunosuppression in neoadjuvant immunotherapy of hepatocellular carcinoma
Nat Commun. 2026 Jul 31;17(1):9381. doi: 10.1038/s41467-026-75949-y.
ABSTRACT
Hepatocellular carcinoma (HCC) is a cancer with high incidence and mortality rate. Although immune checkpoint inhibitors (ICIs) improved survival outcomes for HCC patients, limited objective response rate highlights the urgency of investigating determinants of immunotherapy. Here, we explore HCC resistance mechanisms following neoadjuvant αPD-1 immunotherapy by constructing a comprehensive multi-modal single-cell transcriptomic atlas consisting of 14 HCC patients treated with αPD-1 from our cohort (ClinicalTrials.gov ID: NCT06571396) and 60 external HCC cases with heterogeneous treatment backgrounds. Supervised by clinical outcomes of our cohort, we identify positive and negative regulators of immunotherapy within the tumor immune microenvironment (TIME), especially lipid-associated macrophages (LAM) with increased lipid metabolic state in non-responders and characterized by C1QA, FABP1, and APOA1 expression. We further show the presence, exogenous inducements and immunosuppressive functions of LAM, along with regulation strategies of its lipid-associated condition, including lycopene and chiglitazar. Furthermore, we construct interaction networks of immune regulators across responders and non-responders, showing distinct ligand-receptor landscapes with intervention targets. We reveal the TIME components including immunosuppressive LAMs that influence immunotherapy outcomes, thus providing evidence and insights for exploring immune landscape and therapeutic strategies for HCC immunotherapy. ClinicalTrials.gov ID: NCT06571396.
PMID:42680737 | PMC:PMC13534469 | DOI:10.1038/s41467-026-75949-y
TIGER: Text-Informed Generalized Enzyme-Reaction Retrieval
Security of OpenClaw Agents: Fundamentals, Attacks, and Countermeasures
Harnessing AtomisticSkills for Agentic Atomistic Research
SEP-Attack: A Simple and Effective Paradigm for Transfer-Based Textual Adversarial Attack
MuNet: A Mutualistic Network for Joint 3D Human Mesh Recovery and 3D Clothed Human Reconstruction from Single Images
Agent Learning via Early Experience
JAEGER: Joint 3D Audio-Visual Grounding and Reasoning in Simulated Physical Environments
Grouter: Decoupling Routing from Representation for Accelerated MoE Training
Data Difficulty and the Generalization--Extrapolation Tradeoff in LLM Fine-Tuning
A pathogen lncRNA secreted into rice sequesters a host miRNA for virulence
Nature, Published online: 20 May 2026; doi:10.1038/s41586-026-10572-x
A fungal long non-coding RNA from Magnaporthe oryzae translocates into rice cells to sequester a host microRNA that normally represses PKR1, a negative immunity regulator, thereby facilitating infection and revealing a widespread RNA-based pathogen–host interaction mechanism.Coupling dead cell recognition to Fcγ receptors augments anticancer immunity
Nature Cancer, Published online: 20 May 2026; doi:10.1038/s43018-026-01168-5
Castro-Dopico et al. report the design of reagents to bridge F-actin and Fcγ receptors, endowing a range of antigen-presenting cells with the ability to cross-present antigens from dead tumor cells and boosting antitumor immunity in preclinical models.Genetic predictors of GLP1 receptor agonist weight loss and side effects
Nature, Published online: 08 April 2026; doi:10.1038/s41586-026-10330-z
Identification of genetic variants associated with the efficacy and side effects of GLP1 medications could underpin development of precision medicine approaches in the treatment of obesity.Multi-omics approaches reveal erythroid progenitor cell in cancer: from passive bystander to active player
Oncogene, Published online: 08 April 2026; doi:10.1038/s41388-026-03758-0
Multi-omics approaches reveal erythroid progenitor cell in cancer: from passive bystander to active player